1 / 23

REACH ”No Data, No Market”

REACH ”No Data, No Market”. Elin Simonsson Lena Lundahl Anna Johansson. ”No data, no market”. Art. 5 REACH; EC 1907/2006. Outline. Introduction Provisions Controversy Status/Discussion. History Behind Regulating Information. Expensive and administratively heavy

ashtyn
Download Presentation

REACH ”No Data, No Market”

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. REACH”No Data, No Market” Elin Simonsson Lena Lundahl Anna Johansson

  2. ”No data, no market” • Art. 5 REACH; EC 1907/2006

  3. Outline • Introduction • Provisions • Controversy • Status/Discussion

  4. History Behind Regulating Information • Expensive and administratively heavy • Internalizing cost of information • Market failure • Internal market – art. 114 TFEU

  5. Market-Based Regulation • Compare with the EU ETS • International aviation • Global impact

  6. Art. 5 REACH • […] substances on their own, in preparations or in articles, shall not be manufactured in the Community or placed on the market unless they have been registered […]

  7. Definitions • Art. 3 REACH • 3(1) Substance […] a chemical element and its compounds in the natural state or obtained by any manufacturing process […] • 3(2) Article […] an object which during production is given a special shape, surface or design which determines its function to a greater degree than does its chemical composition […]

  8. Obligation to Register • Art. 6 REACH • General obligation to register substances • If the quantity exceeds 1 tonneannually, per manufacturer

  9. Registration • Art. 7 REACH • Criteria for registration of articles: • Quantity exceeding 1 tonne per year and producer • Substance in article is intended to be released under normal/reasonably foreseeable conditions of use

  10. Registration (cont’d) • Art. 10 REACH: Technical dossier • Information about themanufacturer • Identity of the substance • Information on the manufacture and uses of the substance • Classification and labeling • Guidance of use • Chemical safety report • Study summary • The tonnage range decides what information the registrant needs to submit (Annexes VII-XI)

  11. Notification • Art. 7 REACH • Basic information about the substance might lead to an obligation to register • Criteria for notification: • Substance concentration in article exceeds 0.1%, and • The substance has been classified as: • Cancerogenic • Mutagenic • Toxic to reproduction • Persistent, bioaccumulative and toxic, or • Substances for which there is scientific evidence of probable serious effects to human health or to the environment

  12. Joint Submission of Data • Art. 11 REACH • The lead registrant shall notify the Agency about: • Classification and labeling • Guidance on safe use • Study summaries • Proposals for testing • Every registrant submits information specific to their own import/production • Every single registrant responsible only for the information of their own manufacture or import

  13. Sharing of Costs • Rules dispensed in different parts of the regulation • Art. 27 REACH • ”The previous registrant and potential registrant(s) shall make every effort to ensure that the costs of sharing the information are determined in a fair, transparent and non-discriminatory way.”

  14. Controversy • Privatization of information provision • Obligation on private actors • Explicit responsibility for the industry for the safety of its chemicals • Internalization of costs

  15. Controversy (cont’d) • Perverse incentives for the industry? • Underestimation of risk • Key governance problem of REACH • Two principal mechanisms: • Hierarchical control • Peer review

  16. i. Hierarchical Control • Dossier evaluation • Examination of testing proposals • Compliance check of registration

  17. ii. Data Sharing/Joint Registration (Peer Review) • Title III, articles 25-30 of REACH • REACH requires multiple registrants of the same substance to share data and to jointly submit their registration dossier • Core principle to avoid unnecessary animal testing and reduce registration costs • Mechanism differs depending on whether the chemical is a new (non phase-in) or an existing (phase-in) substance

  18. a. Non Phase-In Substances: Inquiry • Duty to inquire whether a registration has already been submitted for that substance • The Agency has to facilitate joint registration

  19. b. Phase-In Substances: SIEF • Duty to pre-register and to join a Substance Information Exchange Forum (SIEF) • One joint submission for each substance • Cost reduction • Unnecessary animal testing avoided • SIEFs have no prescribed legal form and are independently managed by the industry • ECHA not involved

  20. Controversy (cont’d) • Accountability • Is it a workable regulatory strategy? • Assessment of the quality of the data • Risk assessment • Risk assessment rather than hazard assessment • Costs • Do the costs to private actors exceed the public benefits?

  21. Controversy (cont’d) • Practicalities • Decisions need to be made about different issues: • Risk identification • Information quality • Publication and sharing of information • How is the information to be acted on?

  22. REACH Review 2012 • ”…special attention to the costs and administrative burden and otherimpacts on innovation.”

  23. Discussion • Is a focus on information a goodway to regulate? • From a market perspective? • From an environmentalperspective? • Is it reasonable to put the obligation of information provision on the industry? Is it safe?

More Related